Cargando…

Assessing Silent Cardiotoxicity in Long-Term Lymphoma Survivors Treated With Radiotherapy

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Miller, Eric, Mikrut, Katarzyna, Addison, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702787/ https://www.ncbi.nlm.nih.gov/pubmed/34988479 http://dx.doi.org/10.1016/j.jaccao.2021.11.003

Ejemplares similares

Thyroid Functions in Long-Term Survivors of Pediatric Hodgkin’s Lymphoma Treated with Chemotherapy and Radiotherapy
por: Demirkaya, Metin, et al.
Publicado: (2011)

Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis
por: Kang, Yu, et al.
Publicado: (2018)

Early Detection of Anthracycline-Induced Cardiotoxicity in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Low Cumulative Dose
por: Salvo, Giovanni Di, et al.
Publicado: (2014)

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy
por: Dores, G M, et al.
Publicado: (2010)

Long-Term Adverse Effects of Neck Radiotherapy in Childhood on the Carotid Arteries in Survivors of Hodgkin Lymphoma
por: Popit, Matjaž, et al.
Publicado: (2023)

Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2017)

Cardiac Function in Long-Term Survivors of Childhood Lymphoma
por: Friedberg, Mark K., et al.
Publicado: (2011)

Carfilzomib-induced Cardiotoxicity: An Analysis of the FDA Adverse Event Reporting System (FAERS)
por: Buck, Benjamin, et al.
Publicado: (2022)

Cardiotoxicity screening of long‐term, breast cancer survivors—The CAROLE (Cardiac‐Related Oncologic Late Effects) Study
por: Puckett, Lindsay L., et al.
Publicado: (2021)

Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques: probing the pathology
por: Quyam, Sadia, et al.
Publicado: (2015)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

Fulminant Cardiotoxicity in a Patient With Cardiac Lymphoma Treated With CAR-T Cells
por: Koch, Christian, et al.
Publicado: (2022)

Comparing second cancer risk for multiple radiotherapy modalities in survivors of hodgkin lymphoma
por: Timlin, Claire, et al.
Publicado: (2021)

A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy
por: Bergom, Carmen, et al.
Publicado: (2020)

Long-term survivor of human immunodeficiency virus-associated plasmablastic lymphoma
por: Sharma, Atul, et al.
Publicado: (2013)

Long-term survivor of hepatocellular carcinoma treated with repeated carbon ion radiotherapy and transarterial chemoembolization: a case report
por: Ohtaka, Takeru, et al.
Publicado: (2022)

Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy
por: Shin, Dong-Yeop, et al.
Publicado: (2010)

Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma Treated with Radiotherapy
por: Solanki, Abhishek A., et al.
Publicado: (2013)

Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines
por: Caballero, Rebeca Mata, et al.
Publicado: (2022)

Lack of Cardiotoxicity Endpoints in Prospective Trials Involving Chest Radiation Therapy: A Review of Registered, Latter-Phase Studies
por: Prasad, Rahul N., et al.
Publicado: (2022)

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

Are preterm-born survivors at risk of long-term respiratory disease?
por: Kaczmarczyk, Katarzyna, et al.
Publicado: (2017)

Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma
por: Chen, Jiaqi, et al.
Publicado: (2023)

Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
por: Huynh, T. T. M., et al.
Publicado: (2022)

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
por: Fung, Chunkit, et al.
Publicado: (2018)

Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary
por: Magyari, Ferenc, et al.
Publicado: (2022)

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
por: Lagerlöf, Ingemar, et al.
Publicado: (2022)

Long term outcomes of gastric mucosa‐associated lymphoid tissue lymphoma treated with radiotherapy: A multi‐center retrospective cohort study
por: Smith, Clinton D., et al.
Publicado: (2022)

Evaluation of Cardiotoxic Effects of Anthracyclines by Tissue Doppler Imaging in Survivors of Childhood Cancer
por: Caliskan, Munise, et al.
Publicado: (2021)

Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study
por: Armenian, Saro H., et al.
Publicado: (2022)

Long-term in vitro recording of cardiac action potentials on microelectrode arrays for chronic cardiotoxicity assessment
por: Iachetta, Giuseppina, et al.
Publicado: (2023)

High risk of cardiovascular side effects after treatment of Hodgkin’s lymphoma – is there a need for intervention in long-term survivors?
por: Andersson, Anne, et al.
Publicado: (2021)

Forty years after mediastinal radiotherapy for Hodgkin lymphoma: how late is late cardiotoxicity? A case report
por: Ha, Francis J, et al.
Publicado: (2023)

Altered gyrification in chemotherapy-treated older long-term breast cancer survivors
por: Daniel, Ebenezer, et al.
Publicado: (2023)

Allocated but not treated: the silent 16%
por: Lee, Todd C, et al.
Publicado: (2022)

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
por: Bari, Alessia, et al.
Publicado: (2022)

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma
por: Spicer, J, et al.
Publicado: (2004)

Assessment of late cardiotoxic effects in patients treated for cancer in childhood
por: Kincl, Vladimír, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjar9ml61l2pgu6uaaogjqkf8u